top of page
Search

CPHI Milan 2026: The Pre-Show BD Playbook for CROs and CDMOs

  • Writer: Imen Jelassi
    Imen Jelassi
  • Jul 6
  • 7 min read

Updated: Jul 14

Every October, the global pharmaceutical supply chain compresses into a few halls for three days. For a CRO or CDMO business development team, those three days can produce a quarter of pipeline, or a stack of unscanned badges and an expense report nobody wants to explain. The difference is almost never the booth. It is the work done in the eight weeks before the doors open.

This is the Corstrate pre-show playbook for turning a major pharma trade show into measurable business development, built specifically for contract research and contract manufacturing organizations selling into the US and EU markets.

CPHI Milan 2026 pre-show BD playbook infographic: booth traffic vs pre-booked meetings, event ROI split, 8-week countdown for CROs and CDMOs

Key Takeaways

  • The show is won before it starts: roughly 40% of event ROI comes from pre-event work (targeting and booked meetings), about 20% from execution on the floor, and about 40% from post-show follow-up, per B2B event benchmarks. A great booth cannot rescue weak preparation.

  • Booked meetings beat booth traffic: pre-scheduled meetings with target accounts convert at roughly 3 to 5 times the rate of walk-up conversations, and teams that arrive with 30 to 60 booked meetings consistently outperform those relying on foot traffic.

  • The scale is enormous but crowded: CPHI Milan 2026 is expected to draw more than 62,000 professionals and over 2,400 exhibitors from 165+ countries, so being present is not the same as being found.

  • A growing market rewards the prepared: the pharmaceutical CDMO market is estimated at roughly 172 to 185 billion USD in 2026 and is forecast to grow at about 6 to 9% per year, meaning more buyers are actively shopping for outsourcing partners at events like this.

  • Follow-up is where most ROI leaks out: an estimated 80% of trade show leads never receive any follow-up, yet leads contacted within 24 to 48 hours are about 60% more likely to convert. Your follow-up plan matters as much as your meeting plan.

Why CPHI Milan is worth a real BD investment

CPHI (Convention on Pharmaceutical Ingredients) is the largest gathering of the pharmaceutical ingredients and services supply chain in the world. In 2025, the Frankfurt edition set a record with an estimated 67,000 visitors from more than 166 countries, against the 62,000 that organizers had projected (CPHI / BioPharm International).

CPHI Milan 2026 returns to Fiera Milano from October 6 to 8, 2026, and organizers again expect more than 62,000 professionals and over 2,400 exhibitors, alongside 250+ speakers and 130+ content sessions covering APIs, CDMO and CRO services, formulation, packaging, and AI and technology (CPHI). For a life sciences service provider, that concentration of decision-makers is unmatched. But scale cuts both ways: with thousands of exhibitors competing for the same buyers, presence without a plan is invisible.

The commercial backdrop makes the effort worthwhile. Market research firms estimate the pharmaceutical CDMO market at roughly 172 to 185 billion USD in 2026, growing at about 6 to 9% annually depending on the source and scope (Precedence Research, Fortune Business Insights). Roughly speaking, that means more sponsors are outsourcing more of the drug development and manufacturing value chain every year, and many of them walk these halls to choose partners. If you are unsure how the outsourcing landscape is segmented, our primer on CRO vs CDMO: what's the difference is a useful companion read.

The eight-week countdown: what to do and when

A strong CPHI outcome is a sequence, not a scramble. Here is the cadence Corstrate runs with clients preparing for a major show.

Weeks 8 to 6: define targets and goals

Decide what a successful show actually looks like in numbers, not vibes. Set a target for booked meetings (30 to 60 is a realistic range for a focused BD team), a pipeline goal, and the specific account profiles you want in front of you. Build a named target list: which sponsors, which programs, which decision-makers. This is where a clear ideal customer profile pays off. Our guide to pipeline optimization covers how to define and prioritize those targets.

Weeks 6 to 4: outreach and meeting requests

Start booking. Use the event's official meeting planner, but do not rely on it alone. Direct outreach through email and LinkedIn to your named targets is what fills a calendar. Personalized, specific requests ("we help CDMOs in sterile fill-finish shorten tech transfer, can we compare notes for 20 minutes on Tuesday") outperform generic "come visit our booth" invitations by a wide margin. Our playbook on LinkedIn prospecting for pharma and biotech details the sequences that work here.

Weeks 4 to 2: confirm and prepare

Confirm every meeting with a calendar hold and a location. Research each account so your team walks into each conversation with context: their pipeline stage, recent funding, likely outsourcing needs. Prepare a one-page leave-behind and a crisp qualifying question set. This is also the window to line up any speaking slots, partner receptions, or dinners.

Week 1 and on-site: execute and capture

Run the meetings, qualify hard, and capture every lead digitally with next steps attached, not on paper business cards that get lost. Assign owners to each opportunity before you leave the floor. For a deeper treatment of on-site tactics, see our full life sciences conference meeting generation guide.

Booth traffic vs pre-booked meetings: the numbers

The single most important strategic decision is where you place your energy. The data is not subtle.

Factor

Walk-up booth traffic

Pre-booked target meetings

Relative conversion to opportunity

Baseline

About 3 to 5 times higher

Lead quality

Mixed, mostly unqualified

High, pre-qualified to ICP

Predictability of outcome

Low, depends on foot traffic

High, calendar is set in advance

Share of a strong team's plan

Supporting role

Primary driver

Effort timing

Mostly on-site

Mostly in the 8 weeks before

Industry benchmarks from CEIR suggest a well-executed trade show can deliver a 3:1 to 5:1 revenue-to-cost ratio over a 12-month attribution window (Catalyst Exhibits, citing CEIR). That return is almost entirely a function of the meeting book you build beforehand. Ten pre-booked meetings at a 30% opportunity rate is three new opportunities before you scan a single badge.

The CPHI Milan 2026 targeting angle for CROs and CDMOs

For CPHI Milan 2026, the sharpest BD teams narrow their focus rather than trying to meet everyone. A few angles that consistently produce quality conversations:

Focus on sponsors whose programs match your differentiated capability. A CDMO strong in highly potent APIs or lyophilization should target biotechs with molecules that need exactly that, not the entire attendee list. A CRO with a niche in rare disease or complex bioanalytical work should do the same. Specificity is what earns a booked meeting.

Watch the reshoring and supply-security theme. US and EU buyers are increasingly reevaluating where they manufacture, and Western CDMOs have a timely story to tell. If that is your position, lead with it in outreach.

Use your existing pipeline. Your warmest CPHI meetings are often with accounts already in motion. Layer the event onto deals that are stuck, and use a face-to-face slot to unstick them. If your team is wrestling with the structural hurdles here, our analyses of business development challenges for CDMOs and BD challenges for small and mid-sized CROs go deeper.

The follow-up plan: where most ROI is won or lost

Here is the uncomfortable statistic that should shape your entire approach: an estimated 80% of trade show leads never receive any follow-up, a figure widely attributed to CEIR research (SurFox). Meanwhile, leads contacted within 24 to 48 hours are roughly 60% more likely to convert, and about half of trade show buyers choose the vendor that responds first with relevant information (Gushwork).

Translate that into a rule: before you fly to Milan, your follow-up system is already built. Every lead is captured digitally with a named owner, a qualification note, and a committed next step. Within 48 hours of each meeting, a personalized message goes out referencing the actual conversation, not a templated blast. This is not glamorous, but it is where a good show becomes real revenue. Sustained pipeline also depends on balancing event-driven inbound with steady outbound; our view on inbound vs outbound in life sciences explains why you need both.

Should a boutique CRO or CDMO even exhibit?

Not always. A booth at CPHI is a significant cost, and for smaller service providers the math often favors attending as a delegate with a packed meeting calendar rather than paying for exhibition space. The value of CPHI Milan 2026 for a boutique is the density of decision-makers in one city for three days, and you can capture that value with booked meetings held in the networking areas, partner lounges, or nearby hotels, without the fixed cost of a stand. Decide based on your goals: if brand visibility to thousands matters, exhibit; if you want twenty high-quality conversations with named sponsors, a delegate pass plus a disciplined meeting book can deliver a better return.

This build-versus-attend calculus is exactly the kind of resource-allocation question a fractional business development model is designed to answer, giving smaller companies senior BD firepower for a specific push like a conference without a full-time hire.

Frequently asked questions

When and where is CPHI Milan 2026?

CPHI Milan 2026 takes place October 6 to 8, 2026, at Fiera Milano in Milan, Italy. Organizers expect more than 62,000 professionals and over 2,400 exhibitors from more than 165 countries.

How many meetings should a CRO or CDMO aim to book before the show?

A focused BD team should target roughly 30 to 60 pre-booked meetings. Vendors who arrive with that many booked conversations consistently outperform those relying on booth traffic, because pre-scheduled meetings with target accounts convert at about 3 to 5 times the rate of walk-up conversations.

Is it worth exhibiting, or should we just attend?

It depends on your goal. Exhibiting builds broad visibility but carries a high fixed cost. Many boutique CROs and CDMOs get a stronger return by attending as delegates with a full calendar of pre-booked meetings, capturing the density of decision-makers without paying for a stand.

What is the biggest mistake teams make at CPHI?

Weak or absent follow-up. An estimated 80% of trade show leads are never followed up. Since leads contacted within 24 to 48 hours are about 60% more likely to convert, the follow-up system should be built before the event, not after.

How far in advance should we start preparing?

Begin roughly eight weeks out. Weeks 8 to 6 are for targeting and goal-setting, weeks 6 to 4 for outreach and meeting requests, weeks 4 to 2 for confirmation and account research, and the final week for execution and lead capture.

Sources

Author: Imen Jelassi, Founder, Corstrate, Life Sciences Business Development Consultant.

Comments

bottom of page